(Total Views: 527)
Posted On: 04/04/2020 5:29:15 PM
Post# of 153936
Re: crazyjogger925 #25444
Re: treatment of CV
Use of hydroxychloroquine and use of Leronlimab aren't mutually exclusive outcomes, either on a per patient or global treatment basis.
We should all be rooting for all treatment options to be as effective as possible.
Ultimately, the real success of our investment will be determined by cancer, and CV is slowing down FDA progress in cancer. Imo
Use of hydroxychloroquine and use of Leronlimab aren't mutually exclusive outcomes, either on a per patient or global treatment basis.
We should all be rooting for all treatment options to be as effective as possible.
Ultimately, the real success of our investment will be determined by cancer, and CV is slowing down FDA progress in cancer. Imo
(2)
(0)
